Skin Involvement of Malignant B‐Cell Lymphomas

Abstract
In 1186 patients with systemic malignant B‐cell lymphomas, the skin was involved in 6.17% of low‐grade malignant, 9.7% of medium‐grade malignant, and 7.4% of high‐grade malignant lymphomas. Skin involvement is associated with an impaired prognosis in malignant B‐cell lymphomas, with the exception of medium‐grade malignant lymphomas.